Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations
作者： Charles R. Valliere , Joyce C. Knutson , Charles W. Bishop
DOI:
关键词:
摘要: Method of treating prostatic conditions such as prostate cancer and hyperplasia by administering 1α-hydroxyprevitamin D or activated vitamin a combination thereof in sustained release form delayed formulation. Both the delayed, deliver increase active blood levels without significant risk hypercalcemia associated with other oral dosing forms, to provide beneficial effect diseased tissue.
lens.org 参考文章(28)
Hector F. DeLuca, Yoko Tanaka, Heinrich K. Schnoes, Rafal R. Sicinski, Hydroxyvitamin d2 isomers ,(1984)
Woessner Warren W, Rosenberg Hans R, Stable provitamin d composition ,(1942)
Shigeto Seiwadai Chome Morimoto, Composition for treating skin disease ,(1986)
Sergio A. Lamprecht, Carmen Segal, Shraga Shany, Joseph Kost, Pharmaceutical compositions comprising vitamin-d analogs ,(1995)
Andreas Menrad, Günter Neef, Ruth Thieroff-Ekerdt, Andreas Steinmeyer, Herbert Wiesinger, Katica Schwarz, Gerald Kirsch, Martin Haberey, Novel vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments ,(1996)
Motonari Okumura, Takeshi Noguchi, Masahiro Ariyoshi, Composition for solid pharmaceutical preparations containing active vitamins d3 and process for preparation thereof ,(1991)
H Wilczek, Vachalovský, Importance of vitamin D in prostatic carcinoma Casopís lékar̆ů c̆eských. ,vol. 135, pp. 716- 718 ,(1996)
Joyce C. Knutson, Charles W. Bishop, Robert M. Moriarty, 1.alpha.-hydroxy vitamin d4 and novel intermediates and analogues ,(1991)
Yoshiki Suzuki, Yuji Makino, Gentaro Yamashita, Preparation of pre-1alpha-hydroxycholecalciferol compound ,(1982)
Helen C. Leong, Richard Won, Chung-Heng Cheng, Martin Katz, Controlled release formulations ,(1988)